Security · featured owners
NAMS Newamsterdam Pharma Company
ORDINARY SHARES Equity as of 2026 Q2 among managers we track
- 5 Owners
- Max 2.0%
- $359M
- 2 new 1 add 1 exit
Who owns this now
Largest portfolio weights among featured holders · max 2.0% (Stanley Druckenmiller - D...) · not free-float ownership
holders
sorted by value · long equity only · current book 2026 Q2 · exits show last held size · open a manager for their book
| history | |||||
|---|---|---|---|---|---|
| Andreas Halvorsen - Viking Global Investors 2026 Q2 | 0.41% | Hold | 4,203,567 | $142M | history |
| Lee Ainslie - Maverick Capital 2026 Q2 | 0.98% | Add +49.5% | 3,267,802 | $111M | history |
| Stanley Druckenmiller - Duquesne Family Office 2026 Q2 | 2.0% | Hold | 3,070,146 | $104M | history |
| Palo Alto Investors 2026 Q2 | 0.21% | New 0.21% | 44,359 | $2M | history |
| Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 | <0.01% | New <0.01% | 9,000 | $305K | history |
| Nathan Fischel - Dafna Capital Management exited 2026 Q2 last 2026 Q1 | 0.15% | Exit −0.15 pp | 20,000 | $640K | history |
financials
US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $346.79M | $863.41M | $675.7M |
| Total non-current assets * | $306,000 | $1.21M | $93.58M |
| Total assets | $347.1M | $864.62M | $769.28M |
| Total current liabilities | $49.9M | $106.92M | $85.79M |
| Total non-current liabilities * | $8.81M | $202,000 | $66,000 |
| Total equity | $288.39M | $757.5M | $683.43M |
ownership over time
filing count by report period · click a bar for that quarter’s holders